A recent analysis of the ReCODE Program shows that cognitive impairment patients who undergo the protocol experience relief from both cognitive impairment and depression, according to a release.
ReCODE is a personalized care protocol. It “addresses multiple contributors to cognitive decline — including sleep apnea, pre-diabetes, chronic infections, toxic exposures such as air pollution, and chronic stress.” A group of scientists led by Dr. Ram Rao composed a preprint outlining the benefits of ReCODE for patients with depression. The analysis showed that patients experienced relief from depression after one month of ReCODE. According to Apollo Health, creator of ReCODE, those that were suffering from more severe depression showed the greatest improvements.
